Anders Rosholm

Medicine · Health Sciences

16h-index918citations30works3.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemophilia Treatment and Research(10), Platelet Disorders and Treatments(9), Blood properties and coagulation(6), Dental Radiography and Imaging(4), Bone health and osteoporosis research(3)

Publications30 total

Integrative analysis of VB10.16 and atezolizumab in advanced HPV16-positive cervical cancer: Linking biomarker insights to clinical outcomes.
Journal of Clinical Oncology·2025
Induction of neoantigen-specific immune responses by VB10.NEO in combination with atezolizumab in heavily pretreated patients with advanced solid tumors: Final analysis of the phase 1b VB N-02 trial.
Journal of Clinical Oncology·2025· 1 cited
Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study
Journal for ImmunoTherapy of Cancer·2025· 8 citedOpen Access
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial
The Lancet Neurology·2023· 31 citedOpen Access
Neutralizing interleukin-13 increases skin microbial diversity: results from a Phase 3, randomized, double-blind, placebo-controlled trial of tralokinumab in adult patients with atopic dermatitis
SKIN The Journal of Cutaneous Medicine·2021· 1 citedOpen Access
28170 Neutralizing interleukin-13 increases skin microbial diversity: Results from a phase 3, randomized, double-blind, placebo-controlled trial with tralokinumab in adult patients with atopic dermatitis
Journal of the American Academy of Dermatology·2021· 5 cited
Recombinant FXIII (rFXIII-A2) Prophylaxis Prevents Bleeding and Allows for Surgery in Patients with Congenital FXIII A-Subunit Deficiency
Thrombosis and Haemostasis·2018· 24 citedOpen Access
Safety and Efficacy of Recombinant Factor XIII (FXIII) in Patients with Congenital FXIII A-Subunit Deficiency, Results from the Mentor™2 Trial
Blood·2016
Interim results from a large multinational extension trial (guardian<sup>™</sup>2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A
Haemophilia·2016· 7 cited
Safety update on the use of recombinant activated factor VII in approved indications
Blood Reviews·2015· 50 cited
The use of recombinant activated factor VII in patients with acquired haemophilia
Blood Reviews·2015· 26 cited
New Data on the Safety and Efficacy of Recombinant FXIII in Patients with Congenital FXIII A-Subunit Deficiency
Blood·2014
Pharmacokinetic Characterisation Of Recombinant FXIII Across Age Groups In Patients With FXIII Subunit A Congenital Deficiency
Blood·2013
Pharmacokinetics of recombinant factor <scp>XIII</scp> in young children with congenital <scp>FXIII</scp> deficiency and comparison with older patients
Haemophilia·2013· 16 cited
40K glycoPEGylated, recombinant FVIIa: 3‐month, double‐blind, randomized trial of safety, pharmacokinetics and preliminary efficacy in hemophilia patients with inhibitors
Journal of Thrombosis and Haemostasis·2013· 36 cited
Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency
Blood·2012· 123 citedOpen Access
Safety and pharmacokinetics of a glycoPEGylated recombinant activated factor VII derivative: a randomized first human dose trial in healthy subjects
Journal of Thrombosis and Haemostasis·2011· 35 cited
Recombinant Factor XIII, Safe and Novel Treatment for Congenital Factor XIII Deficiency
Blood·2010· 3 cited
Computerized Digital Imaging Techniques Provided by Digital X-ray Radiogrammetry as New Diagnostic Tool in Rheumatoid Arthritis
Journal of Digital Imaging·2006· 35 citedOpen Access
Computerized Quantification of Joint Space Narrowing and Periarticular Demineralization in Patients With Rheumatoid Arthritis Based on Digital X-Ray Radiogrammetry
Investigative Radiology·2005· 35 cited
page 1 of 2Next →

Frequent Co-authors

Johannes Oldenburg(6), Aida Inbal(5), Manuel Carção(5), Diane J. Nugent(5), Joachim Böttcher(4), Alexander Pfeil(4), Alexander Petrovitch(4), Ansgar Malich(4), Bryce A. Kerlin(4), Ramin Tehranchi(3), Gert Hein(3), Per Arkhammar(3), Werner A. Kaiser(3), Katsuyuki Fukutake(3), May‐Lill Garly(3), Kaja C. G. Berg(3), M. Schäfer(2), Soraya Benchikh El Fegoun(2), Stephanie Seremetis(2), Gabriele Lehmann(2)